Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (I-KRd) in front-line treatment of high-risk Multiple Myeloma: Results of the Safety Run-In cohort in the phase II, multicenter GMMG-CONCEPT trial

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2019-10, Vol.19 (10), p.e17-e17
Main Authors: Weisel, Katja, Asemissen, Anne Marie, Schieferdecker, Aneta, Besemer, Britta, Zago, Manola, Mann, Christoph, Lutz, Raphael, Benner, Axel, Tichy, Diana, Bokemeyer, Carsten, Goldschmidt, Hartmut
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
DOI:10.1016/j.clml.2019.09.024